Open-Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics of Topically Applied IDP-126 Gel in Comparison With Control Gel

Exclusion Criteria

• •1. Use of an investigational drug or device within 30 days of enrollment or participation in a research study concurrent with this study;
• •2. Any dermatological conditions on the face that could interfere with clinical evaluations such as acne conglobata, acne fulminans, secondary acne, perioral dermatitis, clinically significant rosacea, gramnegative folliculitis, dermatitis, eczema;
• •3. Any underlying disease(s) or some other dermatological condition of the face that requires the use of interfering topical or systemic therapy or makes evaluations and lesion count inconclusive;
• •4. Subjects with a facial beard or mustache that could interfere with the study assessments;
• •5. Subjects with more than two (2) facial nodules;
• •6. Evidence or history of cosmetic-related acne